Sebastian Ewen Selected Research

Denervation

1/2022	Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
1/2021	Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension.
1/2021	Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.
5/2020	Effects of renal denervation on 24-h heart rate and heart rate variability in resistant hypertension.
1/2020	The Current Status of Devices for the Treatment of Resistant Hypertension.
1/2020	Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension.
1/2020	Catheter-based renal denervation as adjunct to pulmonary vein isolation for treatment of atrial fibrillation: a systematic review and meta-analysis.
11/2018	Renal Denervation Halts Left Ventricular Remodeling and Dysfunction in Heart Failure: New Shores Ahead.
8/2018	Hypertension: history and development of established and novel treatments.
11/2017	Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sebastian Ewen Research Topics

Disease

48	Hypertension (High Blood Pressure) 01/2022 - 05/2013
13	Heart Failure 03/2022 - 05/2013
4	Atrial Fibrillation 01/2021 - 10/2013
3	Chronic Renal Insufficiency 07/2020 - 09/2013
3	Fibrosis (Cirrhosis) 01/2018 - 05/2013
3	Obstructive Sleep Apnea 01/2017 - 10/2013
3	Cardiogenic Shock 01/2017 - 12/2014
3	Sleep Apnea Syndromes (Sleep Apnea) 11/2014 - 08/2013
2	Hemorrhage 01/2021 - 03/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2020 - 04/2014
2	Isolated Systolic Hypertension 01/2017 - 01/2015
2	Inflammation (Inflammations) 01/2017 - 02/2015
2	Myocardial Infarction 01/2017 - 12/2014
2	Shock 01/2017 - 12/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 04/2014
2	Hypoxia (Hypoxemia) 08/2016 - 10/2013
2	Systolic Heart Failure 02/2016 - 01/2016
1	COVID-19 09/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2022
1	Hypertensive Crisis 01/2021
1	Infections 12/2020
1	Aortic Valve Insufficiency (Aortic Regurgitation) 10/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020
1	unicuspid aortic valve 10/2020
1	Thrombosis (Thrombus) 07/2020
1	Non-ST Elevated Myocardial Infarction 04/2020
1	Arteriovenous Fistula 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Ventricular Remodeling 11/2018
1	Fistula 08/2018
1	Glucose Intolerance 07/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Ventricular Tachycardia 10/2016
1	Hypersensitivity (Allergy) 09/2016
1	Pheochromocytoma 04/2016
1	Essential Hypertension 02/2015
1	Hypertrophy 06/2014
1	Albuminuria 05/2014
1	Diabetes Mellitus 09/2013
1	Metabolic Diseases (Metabolic Disease) 05/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2013
1	Aortic Dissection 01/2013

Drug/Important Bio-Agent (IBA)

14	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 08/2013
3	Pharmaceutical PreparationsIBA 04/2020 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 08/2016 - 12/2014
3	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 05/2013
3	DiureticsIBA 05/2014 - 08/2013
2	C-Reactive ProteinIBA 09/2022 - 02/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 04/2020
2	omega-Chloroacetophenone (Mace)IBA 07/2020 - 05/2020
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 02/2015
2	IvabradineIBA 02/2016 - 01/2016
2	ReninIBA 12/2015 - 09/2013
2	SodiumIBA 08/2015 - 09/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2014 - 05/2013
1	TNF-Related Apoptosis-Inducing LigandIBA 09/2022
1	Proteins (Proteins, Gene)FDA Link 09/2022
1	Interferon-gamma (Interferon, gamma)IBA 09/2022
1	PlasticsIBA 12/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 10/2020
1	iopromide (Ultravist)FDA Link 04/2020
1	MetalsIBA 04/2020
1	mesoglycanIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2018
1	LigandsIBA 01/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 07/2017
1	Neprilysin (Neutral Endopeptidase)IBA 07/2017
1	CH 66IBA 01/2017
1	Receptor for Advanced Glycation End ProductsIBA 01/2017
1	Anti-Arrhythmia AgentsIBA 10/2016
1	Galectin 3 (LGALS3)IBA 08/2016
1	pro-brain natriuretic peptide (1-76)IBA 08/2016
1	Atropine FDA LinkGeneric 08/2016
1	Atenolol (Tenormin)FDA LinkGeneric 08/2016
1	AldosteroneIBA 12/2015
1	Angiopoietin-2IBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 02/2015
1	Tissue Inhibitor of MetalloproteinasesIBA 02/2015
1	Fibroblast Growth Factor-23IBA 12/2014
1	Warfarin (Coumadin)FDA LinkGeneric 03/2014
1	Vitamin K FDA Link 03/2014
1	AnticoagulantsIBA 03/2014
1	Oxidoreductases (Dehydrogenase)IBA 10/2013
1	Connective Tissue Growth FactorIBA 10/2013
1	NADP (NADPH)IBA 10/2013
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2013

Therapy/Procedure

43	Denervation 01/2022 - 01/2013
18	Catheters 01/2021 - 05/2013
16	Therapeutics 01/2020 - 05/2013
15	Sympathectomy (Sympathectomies) 05/2020 - 05/2013
4	Drug Therapy (Chemotherapy) 07/2017 - 05/2013
3	Electrodes (Electrode) 01/2021 - 10/2016
2	Polypharmacy 01/2021 - 07/2017
2	Stents 07/2020 - 04/2020
1	Defibrillators (Defibrillator) 03/2022
1	Drug-Eluting Stents 04/2020
1	Renal Dialysis (Hemodialysis) 01/2019
1	Ligation 01/2019
1	Extracorporeal Membrane Oxygenation 10/2015